摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 4-propynyl-1-(2',3',5'-tribenzoyl-β-D-ribofuranosyl)pyrazole-3-carboxylate | 1002761-61-6

中文名称
——
中文别名
——
英文名称
methyl 4-propynyl-1-(2',3',5'-tribenzoyl-β-D-ribofuranosyl)pyrazole-3-carboxylate
英文别名
methyl 1-[(2R,3R,4R,5R)-3,4-dibenzoyloxy-5-(benzoyloxymethyl)oxolan-2-yl]-4-prop-1-ynylpyrazole-3-carboxylate
methyl 4-propynyl-1-(2',3',5'-tribenzoyl-β-D-ribofuranosyl)pyrazole-3-carboxylate化学式
CAS
1002761-61-6
化学式
C34H28N2O9
mdl
——
分子量
608.604
InChiKey
JXMVVFXRMOYOLP-PYYPWFDZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.7
  • 重原子数:
    45
  • 可旋转键数:
    14
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    132
  • 氢给体数:
    0
  • 氢受体数:
    10

反应信息

  • 作为反应物:
    描述:
    methyl 4-propynyl-1-(2',3',5'-tribenzoyl-β-D-ribofuranosyl)pyrazole-3-carboxylate 作用下, 以 甲醇 为溶剂, 以60%的产率得到4-propynyl-1-β-D-ribofuranosylpyrazole-3-carboxamide
    参考文献:
    名称:
    Effects of Introduction of Hydrophobic Group on Ribavirin Base on Mutation Induction and Anti-RNA Viral Activity
    摘要:
    One of the possible mechanisms of antiviral action of ribavirin (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide, 1) is the accumulation of mutations in viral genomic RNA. The ambiguous incorporation of 5'-triphosphate of ribavirin (RTP, 8) by a viral RNA-dependent RNA polymerase (RdRp) is a key step of the mutation induction. We synthesized three ribavirin analogues that possess hydrophobic groups, 4-iodo-1- 1-beta-D-ribofuranosylpyrazole-3-carboxamide (7a), 4-propynyl-1-beta-D-ribofuranosylpyrazole-3-carboxamide (7b), and 4-phenylethynyl-1-beta-D-ribofuranosylpyrazole-3-carboxamide (7c), and the corresponding triphosphates (9a, 9b, and 9c, respectively). Steady-state kinetics analysis of the incorporation of these triphosphate analogues by a poliovirus RdRp, 3D(pol), revealed that while the incorporation efficiency of 9a was comparable to RTP, 9b and 9c showed lower efficiency than RTP. Antipolioviral activity of 7a and 7b was much more moderate than ribavirin, and 7c showed no antipolioviral activity. Effects of substituting groups on the incorporation efficiency by 3D(pol) and a strategy for a rational design of more active ribavirin analogues are discussed.
    DOI:
    10.1021/jm7009952
  • 作为产物:
    描述:
    1-丙炔-三-正-丁基锡 、 methyl 1-(β-D-2',3',5'-tri-O-benzoylribofuranosyl)-4-iodo-pyrazole-3-carboxylate 在 copper(l) iodide四(三苯基膦)钯 三乙胺 作用下, 以 乙腈 为溶剂, 反应 8.0h, 以75%的产率得到methyl 4-propynyl-1-(2',3',5'-tribenzoyl-β-D-ribofuranosyl)pyrazole-3-carboxylate
    参考文献:
    名称:
    Effects of Introduction of Hydrophobic Group on Ribavirin Base on Mutation Induction and Anti-RNA Viral Activity
    摘要:
    One of the possible mechanisms of antiviral action of ribavirin (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide, 1) is the accumulation of mutations in viral genomic RNA. The ambiguous incorporation of 5'-triphosphate of ribavirin (RTP, 8) by a viral RNA-dependent RNA polymerase (RdRp) is a key step of the mutation induction. We synthesized three ribavirin analogues that possess hydrophobic groups, 4-iodo-1- 1-beta-D-ribofuranosylpyrazole-3-carboxamide (7a), 4-propynyl-1-beta-D-ribofuranosylpyrazole-3-carboxamide (7b), and 4-phenylethynyl-1-beta-D-ribofuranosylpyrazole-3-carboxamide (7c), and the corresponding triphosphates (9a, 9b, and 9c, respectively). Steady-state kinetics analysis of the incorporation of these triphosphate analogues by a poliovirus RdRp, 3D(pol), revealed that while the incorporation efficiency of 9a was comparable to RTP, 9b and 9c showed lower efficiency than RTP. Antipolioviral activity of 7a and 7b was much more moderate than ribavirin, and 7c showed no antipolioviral activity. Effects of substituting groups on the incorporation efficiency by 3D(pol) and a strategy for a rational design of more active ribavirin analogues are discussed.
    DOI:
    10.1021/jm7009952
点击查看最新优质反应信息

文献信息

  • Effects of Introduction of Hydrophobic Group on Ribavirin Base on Mutation Induction and Anti-RNA Viral Activity
    作者:Kei Moriyama、Tetsuya Suzuki、Kazuo Negishi、Jason D. Graci、Corinne N. Thompson、Craig E. Cameron、Masahiko Watanabe
    DOI:10.1021/jm7009952
    日期:2008.1.1
    One of the possible mechanisms of antiviral action of ribavirin (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide, 1) is the accumulation of mutations in viral genomic RNA. The ambiguous incorporation of 5'-triphosphate of ribavirin (RTP, 8) by a viral RNA-dependent RNA polymerase (RdRp) is a key step of the mutation induction. We synthesized three ribavirin analogues that possess hydrophobic groups, 4-iodo-1- 1-beta-D-ribofuranosylpyrazole-3-carboxamide (7a), 4-propynyl-1-beta-D-ribofuranosylpyrazole-3-carboxamide (7b), and 4-phenylethynyl-1-beta-D-ribofuranosylpyrazole-3-carboxamide (7c), and the corresponding triphosphates (9a, 9b, and 9c, respectively). Steady-state kinetics analysis of the incorporation of these triphosphate analogues by a poliovirus RdRp, 3D(pol), revealed that while the incorporation efficiency of 9a was comparable to RTP, 9b and 9c showed lower efficiency than RTP. Antipolioviral activity of 7a and 7b was much more moderate than ribavirin, and 7c showed no antipolioviral activity. Effects of substituting groups on the incorporation efficiency by 3D(pol) and a strategy for a rational design of more active ribavirin analogues are discussed.
查看更多

同类化合物

5-甲基-4-硝基-1-(β-D-呋喃核糖基)-1H-吡唑-3-甲酰胺 1-[(2R,3R,4S,5R)-3,4-二羟基-5-(羟基甲基)四氢呋喃-2-基]吡唑-3,4-二甲酰胺 1-β-D-ribofuranosylpyrazole 4-iodo-3-(3'-methyl-1',2',4'-oxadiazolyl)-1-β-D-ribofuranosylpyrazole 5-amino-1-(2,3,5-tri-O-benzyl-α-D-arabinofuranosyl)pyrazole-4-carboxamide 3,5-dimethyl-1-(2,3,5-tri-O-benzyl-α-D-arabinofuranosyl)pyrazole 4-phenylethynyl-1-β-D-ribofuranosylpyrazole-3-carboxamide 3,5-dimethyl-1-(α-D-arabinofuranosyl)pyrazole methyl 5-amino-1-(2,3,5-tri-O-benzyl-α-D-arabinofuranosyl)pyrazole-4-carboxylate ethyl 1-(2,3-O-isopropylidene-β-D-ribofuranosyl)-5-<(N'-ethoxycarbonylthiocarbamoyl)amino>pyrazole-4-carboxylate methyl 3-[5-amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)-1H-pirazol-4-yl]-4,4,4-trifluoro-3-hydroxybutanoate 5-Amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrazole-4-carboximidamide 1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3-(dimethylaminodiazenyl)pyrazole-4-carboxamide 3-Amino-1-pentofuranosyl-1h-pyrazole-4-carboxamide 5-Amino-1-pentofuranosyl-1h-pyrazole-4-carboxamide 1-(β-D-ribofuranosyl)pyrazole-4-carboxamide 1-(β-D-ribofuranosyl)pyrazole-4-thiocarboxamide 5-bromo-1-(β-D-ribofuranosyl)pyrazole-4-carboxamide 5-bromo-1-(β-D-ribofuranosyl)pyrazole-4-carboxamidoxime 5-amino-1-(β-D-ribofuranosyl)pyrazole-4-carboxamidoxime 1-(β-D-ribofuranosyl)pyrazole-4-carbonitrile 5-bromo-1-(β-D-ribofuranosyl)pyrazole-4-carbonitrile 5-bromo-1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)pyrazole-4-carbonitrile 5-amino-1-(β-D-ribofuranosyl)pyrazole-4-carbonitrile 1-(β-D-ribofuranosyl)pyrazole-4-carboxamidoxime 2-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrazole-3-carboxamide 1H-Pyrazole-3-carboxamide, 1-beta-D-ribofuranosyl- 1H-Pyrazolo-3-carboxamide, 4-amino-1-beta-D-ribofuranosyl- 1H-Pyrazole-5-carboxamide, 4-amino-1-beta-D-ribofuranosyl- 1-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrazole-3,5-dicarboxamide 2-[5-amino-4-(1H-1,2,4-triazol-5-yl)pyrazol-1-yl]-5-(hydroxymethyl)oxolane-3,4-diol Ethyl 2-[3,4-diacetyloxy-5-(acetyloxymethyl)oxolan-2-yl]-4-nitropyrazole-3-carboxylate 1-(2,3-O-isopropylidene-β-D-ribofuranosyl)-3-methyl-5-(methylthio)pyrazole methyl 4-phenylethynyl-1-(2',3',5'-tribenzoyl-β-D-ribofuranosyl)pyrazole-3-carboxylate 3,5-dimethyl-1-(2,3,5-tri-O-benzyl-β-D-arabinofuranosyl)pyrazole methyl 4-propynyl-1-(2',3',5'-tribenzoyl-β-D-ribofuranosyl)pyrazole-3-carboxylate 5-amino-1-(2',3'O-isopropylidene-β-D-ribofuranosyl)pyrazole-4-carboxamide 1-(2,3-O-isopropylidene-β-D-ribofuranosyl)-5-<(N'-benzoyl-S-methylisothiocarbamoyl)amino>pyrazole-4-carboxamide 5-amino-1-(β-D-ribofuranosyl)pyrazole-4-carboxamide methyl 4-iodo-1-β-D-ribofuranosyl-pyrazole-3-carboxylate 5-amino-1-(2,3-O-isopropylidene-β-D-ribofuranosyl)pyrazole-4-carboxaldehyde 1-deoxy-1-N-pyrazolyl-2,3-O-isopropylidene-D-ribofuranose 1-(3,5-dimethyl-pyrazol-1-yl)-O2,O3-isopropylidene-D-1,4-anhydro-ribitol methyl 3-cyanomethyl-1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)pyrazole-4-carboxylate 3-cyanomethyl-1-β-D-ribofuranosylpyrazole-4-carboxamide methyl 3-cyanomethyl-1-β-D-ribofuranosylpyrazole-4-carboxylate 1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-5-(chloromethyl)pyrazole-3-carboxamide 1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-3-(chloromethyl)pyrazole-5-carboxamide 5-amino-1-(β-D-ribofuranosyl)-4-(imidazol-2-yl)pyrazole 4-iodo-1-β-D-ribofuranosylpyrazole-3-carboxamide